Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients

European Journal of Heart Failure

Volumn 9, Issue 12, 2007, Pages 1196-1204

  Murphy, Niamh F ^a   O'Loughlin, Christina ^a   Ledwidge, Mark ^a   McCaffrey, Dermot ^a   McDonald, Kenneth ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

B type natriuretic peptide; Echocardiography; Heart failure; Improvement; Left ventricular function; Return to normal

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL TIME;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOVASCULAR AGENTS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDE, BRAIN; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36248982132     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.10.001     Document Type: Article

References (32)

1. Patrianakos A.P., Parthenakis F.I., Mavrakis H.E., Diakakis G.F., Chlouverakis G.I., and Vardas P.E. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study. Am Heart J 150 5 (Nov 2005) 985
2. Olsen S.L., Gilbert E.M., Renlund D.G., Taylor D.O., Yanowitz F.D., and Bristow M.R. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 25 6 (May 1995) 1225-1231
3. Quaife R.A., Gilbert E.M., Christian P.E., et al. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol 78 7 (Oct 1 1996) 779-784
4. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 15 (Apr 14 2005) 1539-1549
5. Gilbert E.M., Anderson J.L., Deitchman D., et al. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 88 3 (Mar 1990) 223-229
6. Anderson J.L., Gilbert E.M., O'Connell J.B., et al. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 17 6 (May 1991) 1373-1381
7. Waagstein F., Bristow M.R., Swedberg K., et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342 8885 (Dec 11 1993) 1441-1446
8. Eichhorn E.J., Heesch C.M., Barnett J.H., et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 24 5 (Nov 1 1994) 1310-1320
9. Wisenbaugh T., Katz I., Davis J., et al. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 21 5 (Apr 1993) 1094-1100
10. Metra M., Nodari S., Parrinello G., Giubbini R., Manca C., and Dei C.L. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J 145 2 (Feb 2003) 292-299
11. Rahko P.S. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy. Echocardiography 22 7 (Aug 2005) 547-554
12. Lechat P., Packer M., Chalon S., Cucherat M., Arab T., and Boissel J.P. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98 12 (Sep 22 1998) 1184-1191
13. Bello D., Shah D.J., Farah G.M., et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing {beta}-blocker therapy. Circulation 108 16 (Oct 21 2003) 1945-1953
14. Cicoira M., Zanolla L., Rossi A., et al. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 40 2 (Jul 17 2002) 304-310
15. Tsutamoto T., Wada A., Maeda K., et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37 5 (Apr 2001) 1228-1233
16. Levine T.B., Levine A.B., Keteyian S.J., Narins B., and Lesch M. Reverse remodeling in heart failure with intensification of vasodilator therapy. Clin Cardiol 20 8 (Aug 1997) 697-702
17. Cohn J.N., and Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345 23 (Dec 6 2001) 1667-1675
18. John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 15 (Apr 22 2003) 1985-1990
19. Khoury V.K., Haluska B., Fathi R., and Marwick T.H. Effects of revascularisation and contractile reserve on left ventricular remodelling in patients with impaired left ventricular function. Int J Cardiol 93 1 (Jan 2004) 55-61
20. Nicolas J.M., Fernandez-Sola J., Estruch R., et al. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 136 3 (Feb 5 2002) 192-200
21. Guillo P., Mansourati J., Maheu B., et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 79 9 (May 1 1997) 1276-1278
22. Pavan D., Nicolosi G.L., Lestuzzi C., Burelli C., Zardo F., and Zanuttini D. Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: an echocardiographic study. Eur Heart J 8 5 (May 1987) 535-540
23. Figulla H.R., Stille-Siegener M., Mall G., Heim A., and Kreuzer H. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 25 5 (Apr 1995) 1170-1175
24. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 16 (Apr 26 2005) 2050-2055
25. McDonald K., Ledwidge M., Cahill J., et al. Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail 8 3 (Jun 2002) 142-148
26. McDonald K., Ledwidge M., Cahill J., et al. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge. Eur J Heart Fail 3 2 (Mar 2001) 209-215
27. Rector T.S., and Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124 4 (Oct 1992) 1017-1025
28. Rector T.S., Kubo S.H., and Cohn J.N. Patients' self assessment of their congestive heart failure, part 2. content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. 3rd ed. (1987) 198-209
29. Hosmer D., and Lemeshow S. Applied Logistic Regression. 2nd ed (2000), John Wiley & Sons, New York 2000
30. Pieske B. Reverse remodeling in heart failure - fact or fiction?. Eur Heart J Suppl 6 (Aug 1 2004) D66-D78 (suppl_D)
31. Tang W.H., Girod J.P., Lee M.J., et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108 24 (Dec 16 2003) 2964-2966
32. Adams J., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 2 (Feb 2005) 209-216